Heineken Warns UK Pubs of Beer Sales Impact from Weight-Loss Drugs
Heineken has cautioned British pubs and bars that weight-loss drugs like Ozempic and Wegovy could reduce alcohol consumption and threaten beer sales. To adapt, it suggests offering smaller servings, low- and no-alcohol options, and food pairings as the use of GLP-1 drugs increases in the UK market.
Mint Companies·




